Zaza, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 8.199
EU - Europa 7.597
AS - Asia 5.174
SA - Sud America 770
Continente sconosciuto - Info sul continente non disponibili 456
AF - Africa 111
OC - Oceania 12
Totale 22.319
Nazione #
US - Stati Uniti d'America 8.042
RU - Federazione Russa 2.814
SG - Singapore 1.999
CN - Cina 1.550
GB - Regno Unito 1.512
IT - Italia 911
BR - Brasile 593
SE - Svezia 556
FR - Francia 499
VN - Vietnam 471
HK - Hong Kong 403
DE - Germania 360
IE - Irlanda 352
FI - Finlandia 255
KR - Corea 175
IN - India 108
BD - Bangladesh 84
UA - Ucraina 80
CA - Canada 79
ID - Indonesia 72
AR - Argentina 71
TR - Turchia 45
AT - Austria 42
JP - Giappone 42
MX - Messico 40
PK - Pakistan 38
BE - Belgio 34
IQ - Iraq 34
ZA - Sudafrica 34
NL - Olanda 30
PL - Polonia 29
EC - Ecuador 26
ES - Italia 24
CO - Colombia 22
PH - Filippine 21
VE - Venezuela 18
MA - Marocco 14
NG - Nigeria 14
RO - Romania 14
UZ - Uzbekistan 13
CL - Cile 12
SA - Arabia Saudita 12
AU - Australia 11
CZ - Repubblica Ceca 11
IL - Israele 11
PY - Paraguay 11
CH - Svizzera 10
GR - Grecia 10
MY - Malesia 10
AZ - Azerbaigian 9
JO - Giordania 9
DZ - Algeria 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
KZ - Kazakistan 7
PE - Perù 7
EG - Egitto 6
GE - Georgia 6
KE - Kenya 6
LB - Libano 6
LT - Lituania 6
PS - Palestinian Territory 6
BO - Bolivia 5
CR - Costa Rica 5
EU - Europa 5
LV - Lettonia 5
NI - Nicaragua 5
TN - Tunisia 5
XK - ???statistics.table.value.countryCode.XK??? 5
DO - Repubblica Dominicana 4
HN - Honduras 4
HR - Croazia 4
HU - Ungheria 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
NP - Nepal 4
RS - Serbia 4
SV - El Salvador 4
TG - Togo 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BJ - Benin 2
CG - Congo 2
LK - Sri Lanka 2
ME - Montenegro 2
MT - Malta 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
Totale 21.838
Città #
Southend 1.312
Ashburn 1.234
Singapore 1.036
Moscow 943
Chandler 877
San Jose 746
Dallas 511
Jacksonville 465
Hong Kong 397
Council Bluffs 361
Dublin 341
Verona 298
Beijing 265
Woodbridge 262
Ann Arbor 235
The Dalles 225
New York 191
Wilmington 156
Lawrence 150
Princeton 150
Los Angeles 146
Ho Chi Minh City 120
Houston 105
Jinan 102
Santa Clara 83
Buffalo 82
Columbus 80
Redmond 80
Shenyang 80
Hanoi 74
Nanjing 72
Sindelfingen 66
Tianjin 63
Redondo Beach 61
Hebei 59
Munich 58
São Paulo 58
Dong Ket 57
Helsinki 55
Orem 46
Seattle 46
Rome 45
Milan 43
Tokyo 41
Changsha 40
Chicago 38
Jakarta 37
Taizhou 37
Montreal 35
Ningbo 35
Redwood City 35
Boardman 34
Brussels 33
Turku 33
Zhengzhou 32
Haikou 30
Phoenix 30
Lancaster 28
Jiaxing 27
San Francisco 27
Guangzhou 26
Kent 26
Nanchang 26
Vienna 26
Brooklyn 24
Hangzhou 24
Nuremberg 24
Rio de Janeiro 23
Seoul 22
Atlanta 21
Johannesburg 21
Taiyuan 21
Chennai 20
Frankfurt am Main 20
Denver 19
Warsaw 19
Bologna 18
Amsterdam 17
London 17
Mianwali 17
Shanghai 17
Norwalk 16
Toronto 16
Baghdad 15
Da Nang 15
Lanzhou 15
Hyderabad 14
Porto Alegre 14
Brasília 13
Quito 13
Stockholm 13
Washington 13
Abuja 12
Ankara 12
Bari 12
Barnet 12
Biên Hòa 12
Boston 12
Falkenstein 12
Fuzhou 12
Totale 13.109
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 497
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 295
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 261
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 246
Identificazione del primo biomarcatore diagnostico urinario per il rene a spugna midollare (MSK): risultato di uno studio di proteomica mediante spettrometria di massa 215
Terapia della glomerulonefrite membrano proliferativa. 212
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 210
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 206
Liver Metastases From Renal Oncocytoma With Vascular Extension 206
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 203
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 199
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 197
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 196
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 191
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 188
mTOR inhibitors and renal allograft: Yin and Yang. 187
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 187
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 186
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 185
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 185
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 184
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 184
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 183
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 182
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 182
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 181
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 180
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 179
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 176
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 173
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 173
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 173
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis 173
Caratterizzazione del profilo trascrittomico nei linfomonociti periferici di trapiantati renali con rigetto cronico anticorpo-mediato (RCAM) 172
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 172
Assessment of physical performance and body composition in male renal transplant patients 172
Donor-transmitted cancer in kidney transplant recipients: a systematic review 172
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 171
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 171
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 171
Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy 171
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 170
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 166
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
Sulodexide and glycosaminoglycans in the progression of renal disease. 164
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 164
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 164
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 163
Directional dominance on stature and cognition in diverse human populations. 162
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 161
Post-renal transplant pregnancy: a project to plan carefully 160
Dialysis-related systemic microinflammation is associated with specific genomic patterns 160
Mitochondria: a new therapeutic target in chronic kidney disease. 159
mTOR Inhibition Role in Cellular Mechanisms 159
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 159
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 157
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 157
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 157
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 155
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 154
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 154
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 154
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 152
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 151
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 150
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 149
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 148
Aberrantly Methylated DNA Regions Lead to Low Activation of CD4+ T Cells in IgA Nephropathy. 147
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 147
Alla ricerca di biomarker predittivi della ritardata ripresa funzionale del rene trapiantato: un utilizzo innovativo della genomica funzionale in trapiantologia. 146
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 146
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 146
Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients 146
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients. 146
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 145
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 145
Late recovery of renal function in a patient with acute on chronic renal failure treated with peritoneal dialysis. 144
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis 144
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis 143
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 141
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 141
INCIDENCE OF PRIMARY GLOMERULONEPHRITIS IN A LARGE NORTH-EASTERN ITALIAN AREA: A 13-YEAR RENAL BIOPSY STUDY 140
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 140
Analysis of urinary exosomes applications for rare kidney disorders. 140
Heparanase: another renal player controlled by vitamin d. 139
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 138
The UK10K project identifies rare variants in health and disease. 138
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy. 138
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review. 138
Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment 137
Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux 135
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 134
Compiti e funzioni dei Centri Interregionali Trapianto 132
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 132
Predictive model for delayed graft function based on easily available pre-renal transplant variables 131
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. 130
The nephrologist of tomorrow: towards a kidney-omic future. 130
Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment 129
HFR aequilibrium can be an answer to malnutrition and hypotension in dialisys: case report 128
Totale 16.976
Categoria #
all - tutte 78.899
article - articoli 72.966
book - libri 0
conference - conferenze 4.377
curatela - curatele 0
other - altro 603
patent - brevetti 0
selected - selezionate 0
volume - volumi 953
Totale 157.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022967 0 173 16 194 29 32 35 77 45 26 91 249
2022/20232.536 174 342 230 450 200 564 31 142 275 12 87 29
2023/20241.431 60 100 101 118 145 188 33 366 6 69 189 56
2024/20253.090 166 225 122 558 158 96 131 172 465 181 274 542
2025/20269.081 653 450 546 1.444 2.237 674 810 501 654 570 152 390
2026/2027305 111 194 0 0 0 0 0 0 0 0 0 0
Totale 22.319